Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasser Abou-Mourad

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Dermatology|January 25, 2005
Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemiaYasser Abou Mourad, Fadi Jabr, Ziad Salem
Annals of Hematology|April 3, 2004
Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibodyYasser Abou Mourad, Ali Taher, Aref Chehal, et al.
Hemoglobin|July 30, 2002
Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication?Ali Taher, Yasser Abou-Mourad, Antoine Abchee, et al.
Leukemia & Lymphoma|August 31, 2018
Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemiaCraig Speziali, Andrew Daly, Mohamed Abuhaleeqa, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trialGhada El-Hajj Fuleihan, Mariana Salamoun, Yasser Abou Mourad, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Reevaluating Patient Eligibility for Inotuzumab Ozogamicin Based on CD22 Expression: Is Dim Expression Sufficient?Warren Fingrut, Wendy Davis, Eric McGinnis, et al.
American Journal of Clinical Oncology|August 3, 2005
A clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC)Ali Shamseddine, Mohammed Khalifeh, Aref Chehal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
Leukemia & Lymphoma|August 27, 2016
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemiaDavid Kliman, Michael Barnett, Raewyn Broady, et al.
Le Journal Medical Libanais. the Lebanese Medical Journal|June 19, 2009
Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot studyYasser Abou-Mourad, Zaher K Otrock, Jawad A Makarem, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Dermatology|January 25, 2005
Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemiaYasser Abou Mourad, Fadi Jabr, Ziad Salem
Annals of Hematology|April 3, 2004
Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibodyYasser Abou Mourad, Ali Taher, Aref Chehal, et al.
Hemoglobin|July 30, 2002
Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication?Ali Taher, Yasser Abou-Mourad, Antoine Abchee, et al.
Leukemia & Lymphoma|August 31, 2018
Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemiaCraig Speziali, Andrew Daly, Mohamed Abuhaleeqa, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trialGhada El-Hajj Fuleihan, Mariana Salamoun, Yasser Abou Mourad, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Reevaluating Patient Eligibility for Inotuzumab Ozogamicin Based on CD22 Expression: Is Dim Expression Sufficient?Warren Fingrut, Wendy Davis, Eric McGinnis, et al.
American Journal of Clinical Oncology|August 3, 2005
A clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC)Ali Shamseddine, Mohammed Khalifeh, Aref Chehal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
Leukemia & Lymphoma|August 27, 2016
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemiaDavid Kliman, Michael Barnett, Raewyn Broady, et al.
Le Journal Medical Libanais. the Lebanese Medical Journal|June 19, 2009
Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot studyYasser Abou-Mourad, Zaher K Otrock, Jawad A Makarem, et al.
Pageof 3